MRNA May 2024 96.000 put
| Previous close | 0.0100 |
| Open | 0.0100 |
| Bid | 0.0100 |
| Ask | 0.1000 |
| Strike | 96.00 |
| Expiry date | 2024-05-24 |
| Day's range | 0.0100 - 0.0100 |
| Contract range | N/A |
| Volume | |
| Open interest | 5 |
BenzingaChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development
Tuesday, French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and Formation Bio to accelerate drug development projects. Also Read: Drugmaker Sanofi’s Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings. Sanofi said the partnership with OpenAI will allow it to access proprietary data to develop AI models for its biopharma models, while Formation Bio will provide additional engineering resources. The three teams will combine data, software, and tuned models t
Simply Wall St.Selling US$3.3m Of Moderna Stock Rewarded Insiders
Moderna, Inc.'s (NASDAQ:MRNA) stock rose 12% last week, but insiders who sold US$3.3m worth of stock over the last year...
BenzingaStocks, Gold Reach New Record Highs, Cruise Stocks Rally, GameStop Sinks: What's Driving Markets Monday?
Wall Street kicked off the new week on a high note, with all major U.S. indices posting gains and reaching fresh record highs by midday trading in New York, as the bull market momentum remains strong. The S&P 500 index surged to 5,325 points during the session, matching last Thursday’s all-time high. The tech-heavy Nasdaq 100 climbed past 18,670 points, setting new record highs. The Dow Jones remained steady at 40,000, its highest level ever. The rally in metal commodities continued, with gold,
